Skip to main content

Table 3 Multiple logistic analysis for patients with Non-improved group

From: Impact of hemodialysis solutions containing different levels of molecular hydrogen (H2) on the patient-reported outcome of fatigue

 

OR

95% CI

p value

Male

1.16

(0.41–3.27)

0.77

Age (years\)

0.95

(0.90–1.01)

0.08

CVD history

0.89

(0.30–2.59)

0.07

HD vintage (months)

0.99

(0.99–1.00)

0.07

UF (kg)

1.26

(0.53–3.00)

0.59

Dry weight (kg)

1.00

(0.98–1.03)

0.76

CTR (%)

1.10

(0.98–1.22)

0.08

Pre-SBP (mmHg)

1.01

(0.98–1.04)

0.08

Change in SBP (mmHg)

0.99

(0.96–1.02)

0.55

Hb (g/dL)

1.32

(0.73–2.37)

0.34

Antihypertensive agents

3.56

(1.28–9.90)

0.01

Change in post-MPO (%)

0.98

(0.97–1.00)

0.06

  1. Multivariate logistic regression was used to calculate ORs and 95% confidence intervals (95% CI) after simultaneously controlling for multiple potential confounders
  2. OR, odds ratio; HD, hemodialysis; CVD, cardiovascular diseases; UF, ultrafiltration volume; CTR, cardiothoracic ratio; Pre-SBP, pre-HD systolic blood pressure; Change in SBP, pre-HD SBP – post-HD SBP; , hemoglobin; Change in MPO, % change of post-HD serum MPO level.
  3. Data at 8 w were used for UF, dry weight, CTR, pre-SBP, change in SBP, and antihypertensive agents
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us